185 related articles for article (PubMed ID: 23462307)
1. Effect of age at treatment on cognitive performance in patients with cystinosis.
Viltz L; Trauner DA
J Pediatr; 2013 Aug; 163(2):489-92. PubMed ID: 23462307
[TBL] [Abstract][Full Text] [Related]
2. Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: A multicenter sibling cohort study.
Veys K; Zadora W; Hohenfellner K; Bockenhauer D; Janssen MCH; Niaudet P; Servais A; Topaloglu R; Besouw M; Novo R; Haffner D; Kanzelmeyer N; Pape L; Wühl E; Harms E; Awan A; Sikora P; Ariceta G; van den Heuvel B; Levtchenko E
J Inherit Metab Dis; 2023 Jan; 46(1):43-54. PubMed ID: 36117148
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological treatment of nephropathic cystinosis with cysteamine.
Kleta R; Gahl WA
Expert Opin Pharmacother; 2004 Nov; 5(11):2255-62. PubMed ID: 15500372
[TBL] [Abstract][Full Text] [Related]
4. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.
Brodin-Sartorius A; Tête MJ; Niaudet P; Antignac C; Guest G; Ottolenghi C; Charbit M; Moyse D; Legendre C; Lesavre P; Cochat P; Servais A
Kidney Int; 2012 Jan; 81(2):179-89. PubMed ID: 21900880
[TBL] [Abstract][Full Text] [Related]
5. Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis.
Nießl C; Boulesteix AL; Oh J; Palm K; Schlingmann P; Wygoda S; Haffner D; Wühl E; Tönshoff B; Buescher A; Billing H; Hoppe B; Zirngibl M; Kettwig M; Moeller K; Acham-Roschitz B; Arbeiter K; Bald M; Benz M; Galiano M; John-Kroegel U; Klaus G; Marx-Berger D; Moser K; Mueller D; Patzer L; Pohl M; Seitz B; Treikauskas U; von Vigier RO; Gahl WA; Hohenfellner K
Mol Genet Metab; 2022 Aug; 136(4):268-273. PubMed ID: 35835062
[TBL] [Abstract][Full Text] [Related]
6. A systematic literature review of cysteamine bitartrate in the treatment of nephropathic cystinosis.
Medic G; van der Weijden M; Karabis A; Hemels M
Curr Med Res Opin; 2017 Nov; 33(11):2065-2076. PubMed ID: 28692321
[TBL] [Abstract][Full Text] [Related]
7. Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy.
Tsilou ET; Rubin BI; Reed G; Caruso RC; Iwata F; Balog J; Gahl WA; Kaiser-Kupfer MI
Ophthalmology; 2006 Jun; 113(6):1002-9. PubMed ID: 16603246
[TBL] [Abstract][Full Text] [Related]
8. Copper deficiency in patients with cystinosis with cysteamine toxicity.
Besouw MT; Schneider J; Janssen MC; Greco M; Emma F; Cornelissen EA; Desmet K; Skovby F; Nobili F; Lilien MR; De Paepe A; Malfait F; Symoens S; van den Heuvel LP; Levtchenko EN
J Pediatr; 2013 Sep; 163(3):754-60. PubMed ID: 23651769
[TBL] [Abstract][Full Text] [Related]
9. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.
Nesterova G; Williams C; Bernardini I; Gahl WA
Pediatr Nephrol; 2015 Jun; 30(6):945-51. PubMed ID: 25526929
[TBL] [Abstract][Full Text] [Related]
10. Negligible urinary cysteamine loss in cystinosis patients with Fanconi syndrome.
Levtchenko EN; de Graaf-Hess A; Blom HJ; Monnens LA
Clin Nephrol; 2002 May; 57(5):349-51. PubMed ID: 12036193
[TBL] [Abstract][Full Text] [Related]
11. Cysteamine in renal transplantation: A report of two patients with nephropathic cystinosis and the successful re-initiation of cysteamine therapy during the immediate post-transplant period.
Berryhill A; Bhamre S; Chaudhuri A; Concepcion W; Grimm PC
Pediatr Transplant; 2016 Feb; 20(1):141-5. PubMed ID: 26477696
[TBL] [Abstract][Full Text] [Related]
12. Follow-up and treatment of adults with cystinosis in the Netherlands.
Geelen JM; Monnens LA; Levtchenko EN
Nephrol Dial Transplant; 2002 Oct; 17(10):1766-70. PubMed ID: 12270982
[TBL] [Abstract][Full Text] [Related]
13. Neurocognitive functioning in school-aged cystinosis patients.
Besouw MT; Hulstijn-Dirkmaat GM; van der Rijken RE; Cornelissen EA; van Dael CM; Vande Walle J; Lilien MR; Levtchenko EN
J Inherit Metab Dis; 2010 Dec; 33(6):787-93. PubMed ID: 20814825
[TBL] [Abstract][Full Text] [Related]
14. Body growth, upper arm fat area, and clinical parameters in children with nephropathic cystinosis compared with other pediatric chronic kidney disease entities.
Kluck R; Müller S; Jagodzinski C; Hohenfellner K; Büscher A; Kemper MJ; Oh J; Billing H; Thumfart J; Weber LT; Acham-Roschitz B; Arbeiter K; Tönshoff B; Hagenberg M; Kanzelmeyer N; Pavičić L; Haffner D; Zivicnjak M
J Inherit Metab Dis; 2022 Mar; 45(2):192-202. PubMed ID: 34989402
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients.
Bouazza N; Tréluyer JM; Ottolenghi C; Urien S; Deschenes G; Ricquier D; Niaudet P; Chadefaux-Vekemans B
Orphanet J Rare Dis; 2011 Dec; 6():86. PubMed ID: 22195601
[TBL] [Abstract][Full Text] [Related]
16. Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy.
Gahl WA; Balog JZ; Kleta R
Ann Intern Med; 2007 Aug; 147(4):242-50. PubMed ID: 17709758
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical benefits of delayed-release cysteamine bitartrate capsules in patients with nephropathic cystinosis (response to "A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis").
Langman CB
Orphanet J Rare Dis; 2023 Jun; 18(1):162. PubMed ID: 37353838
[TBL] [Abstract][Full Text] [Related]
18. Parenchymal organ cystine depletion with long-term cysteamine therapy.
Gahl WA; Charnas L; Markello TC; Bernardini I; Ishak KG; Dalakas MC
Biochem Med Metab Biol; 1992 Dec; 48(3):275-85. PubMed ID: 1476793
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive functions and behavioral profiles in children with nephropathic cystinosis.
Aly R; Makar S; El Bakri A; Soliman NA
Saudi J Kidney Dis Transpl; 2014 Nov; 25(6):1224-31. PubMed ID: 25394439
[TBL] [Abstract][Full Text] [Related]
20. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
Langman CB; Barshop BA; Deschênes G; Emma F; Goodyer P; Lipkin G; Midgley JP; Ottolenghi C; Servais A; Soliman NA; Thoene JG; Levtchenko EN;
Kidney Int; 2016 Jun; 89(6):1192-203. PubMed ID: 27181776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
